The term 'POTS' (Postural Orthostatic Tachycardia Syndrome) has been a source of frustration for both patients and healthcare professionals alike. While it was initially defined in 1993 by Dr. Philip Lowe, the label has become increasingly problematic as it fails to capture the complexity of the condition and the diverse range of symptoms experienced by patients. This has led to a growing body of research and a push for a more comprehensive understanding of POTS and its management.
Dr. Susan Corcoran, a cardiologist at Bayside Health, highlights the issue with the current label. She argues that it doesn't serve patients well, as many are misdiagnosed or receive inadequate treatment. The term is often misused to describe anyone with frequent symptoms when upright, leading to confusion and frustration among both patients and doctors.
Corcoran suggests that a shift away from a specific label could improve understanding and management. She believes that a broader approach, such as the 'chronic overlapping pain conditions' (COCP) umbrella, could provide a more accurate representation of the diverse symptoms and conditions associated with orthostatic intolerance. This shift could lead to better patient care and a more nuanced understanding of the condition.
The complexity of POTS is further emphasized by the fact that vasovagal syncope, vasovagal presyncope, and orthostatic hypotension are more common than POTS. These conditions share overlapping symptoms and heart rate changes, making diagnosis and treatment challenging. The current focus on heart rate may also overlook other conditions, such as Persistent Postural-Perceptual Dizziness (PPPD) and Vestibular migraine, which are not related to the cardiovascular system.
The impact of POTS on patients' quality of life is significant. Claire Seeley, a research fellow and CEO of the Australian POTS Foundation, notes that 58% of people with POTS don't return to work, and the condition is often disabling. However, the medical system and education have failed to adequately train GPs and clinicians in autonomic disorders, leading to a lack of proper diagnosis and treatment.
The frustration is palpable, as evidenced by online discussions. Patients often express disappointment with doctors who refuse to diagnose POTS, and healthcare professionals themselves are frustrated by the limitations of the current label. Corcoran emphasizes the need for a more nuanced approach, one that considers the complexity of the condition and the diverse range of symptoms.
The push for a name change is not just about semantics but about improving patient care and understanding. By adopting a broader perspective, healthcare professionals can better manage the condition and provide more comprehensive support to patients. The recent change from PCOS to PMOS is a positive example of this shift, focusing on the broader presentation of the condition rather than a specific organ.
In conclusion, the term 'POTS' is in dire need of a refresh to better serve patients and healthcare professionals. A more comprehensive and nuanced approach, such as the COCP umbrella, could lead to improved diagnosis, treatment, and management of this complex condition. The growing body of research and the push for change are essential steps towards a better understanding and management of POTS.
